| Literature DB >> 30847377 |
Hussain S H Jaheer1, Asode Ananthram Shetty2, Nam Yong Choi3, Ki-Won Kim3, Selvan V Thirumal1, Jun Seob Song4, Ki Seong Kim5, You Seung Chun3, Seok Jung Kim3.
Abstract
PURPOSE: High fibular osteotomy (HFO) is a simple surgical technique to reduce pain and improve function in patients with osteoarthritis via fibular osteotomy. We report short-term results of HFO and mesenchymal cell induced chondrogenesis (MCIC) for the treatment of osteoarthritis of knee with varus deformity. PATIENTS AND METHODS: 45 symptomatic patients with 14 males and 31 females age ranging from 40 to 75 years were treated by HFO and MCIC. Main lesions involved medial compartment of knee and lateral compartment with normal to mild lesions of lateral meniscus and articular cartilage, amenable to treatment via partial meniscectomy or observation.Entities:
Keywords: BMAC, bone marrow aspirate concentrate; HA, hyaluronic acid; HFO, High fibular osteotomy; HTO, high tibial osteotomy; High fibular osteotomy; KOOS, Knee injury and Osteoarthritis Outcome score; Knee; MCIC, mesenchymal cell induced chondrogenesis; Mesenchymal cell induced chondrogenesis (MCIC); Osteoarthritis; VAS, visual analogue score; Varus deformity
Year: 2019 PMID: 30847377 PMCID: PMC6389797 DOI: 10.1016/j.reth.2019.02.001
Source DB: PubMed Journal: Regen Ther ISSN: 2352-3204 Impact factor: 3.419
Fig. 1A) Using BMAC(bone marrow aspirate concentrate) kit, BMAC is aspirated after centrifugation of bone marrow aspirate. B) 0.2 ml of hyaluronic acid and 0.8 ml of fibrinogen are loaded in 1 ml syringe and 0.8 ml of BMAC and 0.2 ml of thrombin are loaded in other 1 ml syringe. Two syringes are connected by Y-shape catheter for injection to the cartilage defect.
Fig. 2A) Clinical photo of arthroscopy and CO2 infusion setup for MCIC operation. B) BMAC mixed with hyaluronic acid and fibrinogen is injected to the cartilage defect under CO2 insufflation.
Comparison of the scores before and after surgery N=45.
| Variables | Pre-OP | Post-OP | t or Z | |
|---|---|---|---|---|
| Mean (Standard Deviation, Min-Max) | ||||
| KOOS | 30.2 (9.2, 7.7–50.6) | 83.1 (8.3, 61.3–96.4) | −31.13 | <0.001 |
| VAS | 9.0 (0.8, 7–10.0) | 1.6 (0.8, 0–3.0) | −5.89 | <0.001 |
| Lysholm | 29.2 (7.0, 10.0–46.0) | 81.9 (8.1, 64.0–94.0) | −33.72 | <0.001 |
| X-ray | 10.5 (2.0, 8.0–15.0) | 1.4 (0.9, 0–3.0) | 26.52 | <0.001 |
*Wilcoxon signed rank test.
Comparison of the scores by gender N = 45.
| Variables | Male (n = 14) M (SD, Min-Max) | t or Z | Female (n = 31) M (SD, Min-Max) | t or Z or U | ||||
|---|---|---|---|---|---|---|---|---|
| Pre-OP | Post-OP | Pre-OP | Post-OP | |||||
| KOOS | 26.9(9.4, 7.7–42.3) | 83.3(8.0, 70.1–94.6) | −17.50 | <0.001 | 31.7 (8.8, 16.7–50.6) | 83.1(8.5, 61.3–96.4) | −26.17 | <0.001 |
| VAS | 9.3 (0.6, 8.0–10.0) | 1.3 (0.9, 0.0–3.0) | −3.32 | <0.001* | 8.9 (0.8, 7.0–10.0) | 1.7 (0.8, 0.0–3.0) | −4.91 | <0.001 |
| Lysholm | 30.2(9.1,10.0–46.0) | 83.1(7.5, 71.0–94.0) | −14.37 | <0.001 | 28.7 (5.9, 18.0–45.0) | 81.4 (8.4, 64.0–93.0) | −32.93 | <0.001 |
| X-ray | 10.4(1.9, 8.0–15.0) | 1.3 (1.0, 0.0–3.0) | −3.32 | <0.001* | 10.6 (2.1, 8.0–15.0) | 1.4 (0.8, 0.0–3.0) | −4.90 | <0.001 |
| KOOS diff. | 56.5 (12.1, 31.4–76.8) | 51.4 (10.9, 27.0–69.2) | −1.41 | 0.167 | ||||
| VAS diff. | −8.0 (1.2, −10.0 to −6.0) | −7.2 (1.2, −9.0 to −4.0) | 143.00 | 0.061† | ||||
| Lysholm diff. | 52.9 (13.8, 34.0–82.0) | 52.6 (8.9, 38.0–71.0) | −0.07 | 0.943 | ||||
| X-ray diff. | −9.1 (2.5, −15.0 to −6.0) | −9.2(2.3, −15.0 to −6.0) | 207.50 | 0.812† | ||||
*Wilcoxon signed rank test, diff: Differences in scores before and after surgery; †: Mann–Whitney test.
Comparison of the scores by age group.
| Variables | A group (n = 21) | B group (n = 15) | C group (n = 9) | F or χ2 | |
|---|---|---|---|---|---|
| M (SD, Min-Max) | |||||
| Pre OP | |||||
| KOOS | 30.8 (9.7, 7.7–50.6) | 28.8 (8.6, 16.1–48.8) | 31.1 (9.9, 19.6–48.6) | 0.24 | 0.785 |
| VAS | 9.0 (0.7, 8.0–10.0) | 8.9 (0.9, 7.0–10.0) | 9.1 (0.9, 7.0–10.0) | 0.13 | 0.937* |
| Lysholm | 31.0 (7.8, 10.0–46.0) | 27.2 (6.3, 18.0–37.0) | 28.4 (5.3, 22.0–37.0) | 1.36 | 0.268 |
| X-ray | 10.5 (2.0, 8.0–15.0) | 10.6 (2.1, 8.0–15.0) | 10.4 (2.2, 8.0–15.0) | 0.04 | 0.979* |
| Post OP | |||||
| KOOS | 83.7 (8.2, 61.3–94.6) | 86.4 (6.0, 78.0–96.4) | 76.4 (8.6, 67.3–90.2) | 4.91 | 0.012 (B > C) |
| VAS | 1.5 (0.9, 0.0–3.0) | 1.5 (0.8, 0.0–3.0) | 1.9 (0.8, 1.0–3.0) | 0.47 | 0.792* |
| Lysholm | 82.9 (8.4, 64.0–94.0) | 83.9 (5.8, 70.0–92.0) | 76.2 (8.6, 66.0–92.0) | 3.14 | 0.053 |
| X-ray | 1.6 (0.8, 0.0–3.0) | 1.3 (1.0, 0.0–3.0) | 1.1 (0.8, 0.0–2.0) | 2.12 | 0.347* |
| Difference | |||||
| KOOS | 52.9 (10.1, 36.9–76.8) | 57.5 (8.5, 36.3–67.4) | 45.3 (15.0, 27.0–67.3) | 3.61 | 0.036 (B > C) |
| VAS | −7.6 (1.1, −10.0 to −6.0) | −7.5 (1.2, −9.0 to −5.0) | −7.2 (1.6, −9.0 to −4.0) | 1.48 | 0.478* |
| Lysholm | 51.9 (10.9, 34.0–82.0) | 56.7 (9.4, 40.0–71.0) | 47.8 (9.7, 34.0–64.0) | 2.29 | 0.114 |
| X-ray | −9.0 (2.3, −15.0 to −6.0) | −9.3 (2.3, −15.0 to −7.0) | −9.3(2.7, −14.0 to −6.0) | 0.24 | 0.886* |
A group: < 60 years of age; B group <70 years of age; C group > 71 years of age; *: Kruskal–Wallis test.
Fig. 3Knee standing AP radiograph of 70 years old female with medial compartment osteoarthritis. A) 8 degree of varus deformity in anatomical axis of right knee, preoperatively, B) 1 degree of varus deformity in post-operative 6 months.
Fig. 4Lower extremity standing AP radiograph of 54 years old female with medial compartment osteoarthritis. A) 7 degree of varus deformity in mechanical axis of left knee, B) 1 degree of varus deformity in post-operative 6 months.